We are monitoring the impact of COVID-19 on Europe Musculoskeletal Diseases Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7167
Share on
Share on

Europe Musculoskeletal Diseases Market Research Report – Segmented By Type, Type Of Molecules & Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7167
Pages: 145

Europe Musculoskeletal Diseases Market Size (2021 to 2026)

The size of the Europe Musculoskeletal Diseases Market is estimated to be growing at a healthy CAGR from 2021 to 2026. The European Musculoskeletal Diseases market is developing at a rapid pace.

The market for musculoskeletal diseases in the European region is projected to be fuelled by improving the quality of life in the geriatric population, increasing healthcare expenditure. Also, the technological advancements in orthopedic products devices are expected to influence the market growth. In addition, increasing investment and funding by the government and private organizations provide lucrative opportunities for healthcare suppliers and providers. However, the growing demand for physical, occupational, and medical therapies is expected to propel market growth. Furthermore, the growth in the elderly population and an increase in orthopedic physicians specializing in sports medicine, joint, hand, and spine replacement are driving the European musculoskeletal medicine market.

On the other hand, the market will be influenced by the growing demand for medications that may improve bone density and rebuild lost bone and strength, fuelled by the lack of a good cure for psoriatic arthritis. Musculoskeletal disorders are the sixth leading cause of mortality due to disability, as per the World Health Organization. In both industrialized and developing nations, one out of every four persons suffers from chronic musculoskeletal damage. Thus, musculoskeletal disorders are a serious health concern in the healthcare system that affects the general public. These diseases demand a significant amount of healthcare resources, accounting for about a quarter of the total cost of illness in developed countries. Musculoskeletal problems are also the most prevalent cause of physical impairment in people who suffer from severe long-term pain.

The European Agency for Safety and Health at Work (EU-OSHA) recommends a series of preventive actions that include developing ergonomic solutions to reduce risk factors such as proper tool use and ergonomic design, ergonomic workstation layout, and the physical work environment, optimized manufacturing configuration, appropriate product design, and the ergonomic pattern of the activity implying alternation of repetitive and non-repetitive tasks for employee awareness.

However, the primary concern for the hospitals is that the risk of side effects of the musculoskeletal disease treatment hinders the market growth. In addition, the high cost of musculoskeletal disease medication research and development, as well as stringent government rules and a complicated government approval procedure, are likely to impede the market growth.

This research report on the European Musculoskeletal Diseases market has been segmented and sub-segmented into the following categories:

By Type:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Osteoporosis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others

By Type of Molecules:

  • Biologics
  • Small Molecules

By Treatment:

  • Biologics
  • Corticosteroids
  • Parathyroid Hormone
  • Protein Therapy
  • Selective Estrogen Receptor Modulators
  • Synthetic Bone Graft
  • Composite Grafts
  • Demineralized Bone Matrix
  • BMPS

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European market held the second most market share in the global Musculoskeletal Diseases Market in 2020. The growth in the number of orthopedic specialists specialized in sports medicine, joint, hand, and spine replacement is driving the European musculoskeletal medicine market. In addition, other factors such as the willingness to live longer, availability of treatment options, and growing awareness among the people about the disease are augmenting the market growth. The developed countries such as Germany, UK, France, Spain, and Italy are expanding the European regional market growth. Over the forecast period, Germany recorded a significant share in the Musculoskeletal Diseases Market with a substantial market share. The factors such as Increasing awareness among people regarding the disease and its treatment options and willingness to live longer are also factors contributing to the market's growth. 

Similarly, the UK is anticipated to witness a significant share in the coming years due to the government's technological advancement and favorable reimbursement policies. Again, advanced academic training for musculoskeletal medicine specialists such as medical physicians, nurses, occupational therapists, physiotherapists, and other allied healthcare professionals, community practitioners, and researchers is projected to strengthen the field.

On the other hand, Italy, France, and Spain are likely to showcase a moderate share and expanding European regional market growth. The increasing prevalence of bone disorders and joint-related injuries is another factor driving the demand for musculoskeletal drugs across these countries.

KEY MARKET PLAYERS:

AbGenomics International, AB Sciences, Ablynx, Akron Molecules, Johnson & Johnson, F. Hoffmann-La Roche, Pfizer, Eli Lilly, Adheron, Alder BioPharmaceuticals, Bioiberica, Bone Therapeutics, Edding Pharm, Boehringer Ingelheim, Can-Fite BioPharma, Celltrion, Celgene Corp., Cellular Biomedicine, ChemoCentryx, Cerapedics, Eupraxia Pharmaceuticals, and GlaxoSmithKline are the some of the key players in the Europe Musculoskeletal Diseases market.

  1. 1.Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. Epidemology
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Type
        1. Introduction
        2. Rheumatoid Arthritis
        3. Osteoarthritis
        4. Osteoporosis
        5. Psoriatic Arthritis
        6. Ankylosing Spondylitis
        7. Fibromyalgia
        8. Others
        9. Y-o-Y Growth Analysis, By Type
        10. Market Attractiveness Analysis, By Type     
        11. Market Share Analysis, By Type
    2. Type Of Molecules                                                                  
        1. Introduction              
        2. Biologics                    
        3. Small Molecules       
        4. Y-o-Y Growth Analysis, By Type Of Molecules                 
        5. Market Attractiveness Analysis, By Type Of Molecules 
        6. Market Share Analysis, By Type Of Molecules                 
    3. Treatment                                                                  
      1. Introduction                                      
      2. Biologics                                  
      3. Corticosteroids                                 
      4. Parathyroid Hormone                     
      5. Protein Therapy                               
      6. Selective Estrogen Receptor Modulators                                       
      7. Synthetic Bone Graft                       
      8. Composite Grafts                                                 
      9. Demineralized Bone Matrix           
      10. BMPS                                                  
      11. Y-o-Y Growth Analysis, By Treatment                            
      12. Market Attractiveness Analysis, By Treatment  
      13. Market Share Analysis, By Treatment 
  6. Geographical Analysis                                                                                              
    1. Introduction                                                              
      1. Regional Trends                                
      2. Impact Analysis                                
      3. Y-o-Y Growth Analysis                     
        1. By Geographical Area                            
        2. By Type                      
        3. By Type Of Molecules                 
        4. By Treatment            
      4. Market Attractiveness Analysis     
        1. By Geographical Area                            
        2. By Type                      
        3. By Type Of Molecules                 
        4. By Treatment            
      5. Market Share Analysis                    
        1. By Geographical Area                            
        2. By Type                      
        3. By Type Of Molecules                 
        4. By Treatment            
    2. United Kingdom
    3. Germany
    4. France
    5. Spain
    6. Italy
    7. Rest of Europe                                                         
  7. Strategic Analysis                                                                                       
    1. PESTLE analysis                                                         
      1. Political                                              
      2. Economic                                           
      3. Social                                                  
      4. Technological                                    
      5. Legal                                                   
      6. Environmental                                  
    2. Porter’s Five analysis                                               
      1. Bargaining Power of Suppliers       
      2. Bargaining Power of Consumers   
      3. Threat of New Entrants                  
      4. Threat of Substitute Products and Services                                             
      5. Competitive Rivalry within the Industry                                             
  8. Market Leaders' Analysis                                                                                        
    1. Johnson & Johnson Private Limited                                                                 
        1. Overview                   
        2. Product Analysis      
        3. Financial analysis     
        4. Recent Developments          
        5. SWOT analysis          
        6. Analyst View             
    2. Stryker Corporation                                                 
    3. Akron Molecules                                                      
    4. Adheron                                                                     
    5. Bone Therapeutics                                                   
    6. Boehringer Ingelheim                                             
    7. ChemoCentryx                                                          
    8. Daiichi Sankyo                                                          
    9. GlaxoSmithKline                  
    10. Eupraxia Pharmaceuticals                                      
  9. Competitive Landscape                                                                   
    1. Market share analysis                                             
    2. Merger and Acquisition Analysis                           
    3. Agreements, collaborations and Joint Ventures         
    4. New Product Launches                                           
  10. Market Outlook and Investment Opportunities
  11. Appendix                                                                                           
  12. List of Tables                                                                
  13. List of Figures

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  2. Europe Rheumatoid Arthritis  Market, By Region, From 2021 to 2026 (USD Billion)
  3. Europe Osteoarthritis  Market, By Region, From 2021 to 2026 (USD Billion)
  4. Europe Osteoporosis Market, By Region, From 2021 to 2026 (USD Billion)
  5. Europe Psoriatic Arthritis Market, By Region, From 2021 to 2026 (USD Billion)
  6. Europe Ankylosing Spondylitis  Market, By Region, From 2021 to 2026 (USD Billion)
  7. Europe Fibromyalgia Market, By Region, From 2021 to 2026 (USD Billion)
  8. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  9. Europe Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)
  10. Europe Biologics Market, By Region, From 2021 to 2026 (USD Billion)
  11. Europe Small Molecules Market, By Region, From 2021 to 2026 (USD Billion)
  12. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  13. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  14. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  15. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  17. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  18. Europe Musculoskeletal Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  19. U.K. Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  20. U.K. Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)
  21. Germany Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  22. Germany Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)
  23. France Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  24. France Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)
  25. Italy Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  26. Italy Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)
  27. Spain Musculoskeletal Diseases Market, By Disease Type, From 2021 to 2026 (USD Billion)
  28. Spain Musculoskeletal Diseases Market, By Type of molecules, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample